Tag: Novo Nordisk
Wegovy approved to prevent heart problems or strokes in obese and overweight adults
A post-approval clinical study showed that Wegovy significantly reduced the risk of major adverse cardiovascular events by 20% compared to a placebo
The Medicines and...
Weight loss drug Semaglutide may increase risk of rare eye condition, study warns
Semaglutide is available as Ozempic for treating type 2 diabetes and as Wegovy for managing overweight and obesity
Amid the rapid rise in semaglutide usage,...
WHO issues alert on fake copies of Novo Nordisk’s diabetes drug Ozempic
Falsified batches of Ozempic (semaglutide) were detected in Brazil, the UK, Northern Ireland and the United States
The World Health Organization (WHO) issued a...
Inventor gifts tablet press to the University students
The equipment (Tablet Press Machine) can be used in pharmaceutical studies as well as metallurgy and 3D printing
Dr Michael Gamlen, the inventor of Gamlen...
Chemist4U receives £12 million capital infusion from Pitalia Capital
Skelmersdale-based online pharmacy Chemist4U has secured a £12 million investment from Pitalia Capital, an equity investment company led by Anil Pitalia.
Chemist4U is part of...
Novo Nordisk launches weight-loss drug Wegovy in the UK market
Novo Nordisk, the Danish drug manufacturer, has launched Wegovy, a weight-loss drug, in the UK market. This semaglutide injection will be available through specialist...